BioReference Laboratories, Inc. Financial Analyst Salaries in Hagerstown, MD
The average BioReference Laboratories, Inc. Financial Analyst in Hagerstown, MD earns an estimated $92,198 annually, which includes an estimated base salary of $82,615 with a $9,583 bonus. BioReference Laboratories, Inc. Financial Analyst compensation is $4,798 more than the US average for a Financial Analyst. Financial Analyst salaries at BioReference Laboratories, Inc. in Hagerstown, MD can range from $30,000 - $162,000.
In Hagerstown, MD, The Finance Department at BioReference Laboratories, Inc. earns $15,280 more on average than the Customer Support Department.
Last updated 2 years ago.
- $82,615
- avg. base
- $9,583
- avg. bonus
Financial Analyst Salaries at BioReference Laboratories, Inc.
In Hagerstown, MD, Financial Analysts earn $3,206 more than Financial Analysts, and $21,963 less than Accounting Managers.
Compensation at BioReference Laboratories, Inc. by Department
In Hagerstown, MD, The Finance Department averages $15,280 more than the Customer Support Department, and $7,382 less than the Operations Department
Financial Analyst Compensation by Gender (All Companies)
The average female Financial Analyst at companies similar size to BioReference Laboratories, Inc. reported making $89,840, while the average male Financial Analyst at similar sized companies reported making $94,632.
Financial Analyst Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Financial Analyst at companies similar size to BioReference Laboratories, Inc. reported making $97,825, while the average African American/Black Financial Analyst at similar sized companies reported making $68,750.
How Financial Analysts at BioReference Laboratories, Inc. Rate Their Compensation
The majority of Financial Analysts at BioReference Laboratories, Inc. believe they're not compensated fairly. The vast majority (79%) of Financial Analysts at BioReference Laboratories, Inc. are satisfied with their benefits. See more compensation ratings at BioReference Laboratories, Inc.
